-
Finitude and melancholy Brain (IF 10.6) Pub Date : 2025-06-03
Jesus Ramirez-BermudezDrawing on two decades of clinical experience with affective disorders, Jesús Ramírez-Bermúdez— runner up in the Brain Essay Competition 2024—explores the cultural significance of melancholy, with the aid of historical archives from the Inquisition and the introspections of a 17th century poet.
-
Snatches of time. Fragments Brain (IF 10.6) Pub Date : 2025-06-03
Matthew ButlerMatt Butler, runner up in the Brain Essay Competition 2024, considers what happens when memories fragment and certainties fade in this fictional tale of a professor of literature who loses her grasp on time.
-
The parasagittal dural space of the human brain Brain (IF 10.6) Pub Date : 2025-06-02
Manus J Donahue, Colin D McKnight, Daniel O Claassen, Kilian HettThe historical understanding of cerebrospinal fluid (CSF) production and flow comprises CSF production primarily in the choroid plexus of the 1st-3rd ventricles, flow through the aqueduct of Sylvius en route to the 4th ventricle, circulation around the subarachnoid space, and ultimately resorption into the blood circulation through arachnoid granulations. Since the discovery of a perivascular CSF clearance
-
Mild behavioural impairment-apathy and core Alzheimer’s disease cerebrospinal fluid biomarkers Brain (IF 10.6) Pub Date : 2025-06-02
Daniella Vellone, Rebeca Leon, Zahra Goodarzi, Nils D Forkert, Eric E Smith, Zahinoor IsmailApathy is a common neuropsychiatric symptom (NPS) in Alzheimer’s disease (AD) but can emerge earlier in prodromal and even preclinical stages as part of mild behavioural impairment (MBI-apathy), a syndrome defined by emergent and persistent NPS. In dementia, apathy is associated with higher morbidity, mortality, and caregiver distress. However, the significance of MBI-apathy in dementia-free persons
-
Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway Brain (IF 10.6) Pub Date : 2025-06-02
Yoko Hirano, Yuri Miyazaki, Daisuke Ishikawa, Hiroki Inahashi, Zuhair Nasser Al-Hassnan, Giovanni Zifarelli, Peter Bauer, Javeria Raza Alvi, Tipu Sultan, Michelle L Thompson, Abdullah Sezer, Bahadır Konuşkan, Razan S Hajir, Ayman W El-Hattab, Stephanie Efthymiou, Ayuki Ishida, Norihiko Yokoi, Hans-Christian Kornau, Dietmar Schmitz, Harald Prüss, Henry Houlden, Yuji Ikegaya, Yuko Fukata, Masaki FukataMonoallelic pathogenic variants in LGI1 cause autosomal dominant epilepsy with auditory features with onset in childhood/adolescence. LGI1 is a secreted neuronal protein, functions as a ligand for ADAM22/23, and regulates excitatory synaptic transmission and neuronal excitability in the brain. While biallelic ADAM22 variants cause developmental and epileptic encephalopathy (DEE), the whole picture
-
Modelling fragile X-associated neuropsychiatric disorders in young inducible 90CGG premutation mice Brain (IF 10.6) Pub Date : 2025-05-30
Gürsel Çalışkan, Sara Enrile Lacalle, Emre Kul, Miguel del Ángel, Allison Loaiza Zambrano, Renate Hukema, Mónica Santos, Oliver StorkFragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a preCGG repeat expansion in the FMR1 gene. Individuals with the FMR1 premutation often exhibit neuropsychiatric symptoms before FXTAS onset, leading to the identification of fragile X-associated neuropsychiatric disorders (FXAND). Rodent models of FXTAS show motor impairments, pathological intranuclear
-
Correction to: Toxic effects of mutant huntingtin in axons are mediated by its proline-rich domain. Brain (IF 10.6) Pub Date : 2025-05-29
-
PACAP and migraine Brain (IF 10.6) Pub Date : 2025-05-29
Hans Christoph DienerA number of neuropeptides including pituitary adenylate cyclase-activating polypeptide (PACAP) play an important role in the pathophysiology of migraine. Infusions of PACAP in patients with migraine can provoked migraine attacks. A placebo-controlled study with a monoclonal antibody directed against the PACAP-receptor failed to show efficacy. In a small, short, proof of concept study a monoclonal antibody
-
CSF proteomics of semorinemab Alzheimer’s disease trials identifies cell-type specific signatures Brain (IF 10.6) Pub Date : 2025-05-28
Alyaa M Abdel-Haleem, Ellen Casavant, Balazs Toth, Edmond Teng, Cecilia Monteiro, Nikhil J Pandya, Caspar Glock, Casper C Hoogenraad, Brad A Friedman, Felix L Yeh, Veronica G Anania, Gloriia NovikovaTargeting of tau pathology has long been proposed as a potential therapeutic strategy for Alzheimer’s disease (AD). Semorinemab is a humanized IgG4 monoclonal antibody that binds to all known isoforms of full-length tau with high affinity and specificity. Semorinemab’s safety and efficacy have been studied in two Phase 2 randomized, double-blind, placebo-controlled, parallel-group clinical trials:
-
SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamics Brain (IF 10.6) Pub Date : 2025-05-26
Dulcie Lai, Paulina Sosicka, Damian J Williams, MaryAnn E Bowyer, Andrew K Ressler, Sarah E Kohrt, Savannah J Muron, Peter B Crino, Hudson H Freeze, Michael J Boland, Erin L HeinzenSLC35A2 encodes a UDP-galactose transporter essential for glycosylation of proteins and galactosylation of lipids and glycosaminoglycans. Germline genetic SLC35A2 variants have been identified in congenital disorders of glycosylation and somatic SLC35A2 variants have been linked to intractable epilepsy associated with malformations of cortical development. However, the functional consequences of these
-
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing Brain (IF 10.6) Pub Date : 2025-05-26
Gael Moquin-Beaudry, Lovatiana Andriamboavonjy, Sebastien Audet, Laura K Hamilton, Antoine Duquette, Sylvain Chouinard, Michel Panisset, Martine TetreaultParkinson’s disease is most recognized for its impact on the CNS. However, recent breakthroughs underscore the crucial role of interactions between central and peripheral systems in Parkinson’s disease pathogenesis. The spotlight is now shifting as we explore beyond the CNS, discovering that peripheral changes such as inflammatory dysfunctions may predict the rate of disease progression and severity
-
Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder Brain (IF 10.6) Pub Date : 2025-05-26
Ryul Kim, Bora Jin, Heejung Kim, Kyung Ah Woo, Eun Jin Yoon, Seoyeon Kim, Jung Hwan Shin, Hyunwoo Nam, Yu Kyeong Kim, Beomseok Jeon, Jee-Young LeeAlthough growing evidence suggests that cholinergic basal forebrain degeneration is linked to cognitive impairment and axial motor symptoms in Lewy body disorders (LBDs), the cholinergic contribution to their prodromal phase remains largely unknown. Herein, we aimed to address three important yet unresolved questions focusing on prodromal LBDs: (1) to examine whether and where basal forebrain degeneration
-
Oligoadenylate synthetase 1a suppresses prion infection through binding to cellular prion protein Brain (IF 10.6) Pub Date : 2025-05-23
Takujiro Homma, Takehiro Nakagaki, Takuya Nishinakagawa, Yurie Morita, Ryuichiro Atarashi, Shigeru Kakuta, Yoichiro Iwakura, Noriyuki Nishida, Daisuke IshibashiPrion diseases are fatal neurodegenerative disorders caused by misfolding of the normal prion protein (PrPC) into its infectious β-sheet-rich isoform (PrPSc). Conventionally, prions were thought to be incapable of eliciting robust immune responses because PrPC and PrPSc share an identical primary structure. However, recent evidence highlights the critical involvement of type I interferon (I-IFN) signaling
-
Models of autoantibody mediated diseases: actively nearing the human gold standard. Brain (IF 10.6) Pub Date : 2025-05-23
Sarosh R Irani -
Neural substrates of the link between dual-task gait and dementia: an intermediary step in which direction? Brain (IF 10.6) Pub Date : 2025-05-21
A Charlotte Menart,M Arfan Ikram,Frank J Wolters -
Reply: Neural substrates of the link between dual-task gait and dementia: an intermediary step in which direction? Brain (IF 10.6) Pub Date : 2025-05-21
Pauline Ali,Frederico Pieruccini-Faria,Cédric Annweiler,Mickaël Dinomais,Surim Son,Scott K Wilson,Richard Camicioli,Susan Muir-Hunter,Robert Bartha,Manuel Montero-Odasso -
Pure autonomic failure: a natural history study of the Queen Square cohort Brain (IF 10.6) Pub Date : 2025-05-21
Giacomo Chiaro, Ekawat Vichayanrat, Shiwen Koay, Antoine Rogeau, Gordon T Ingle, Patricia McNamara, Laura Watson, Jamshed Bomanji, Christopher J Mathias, Valeria IodiceThe current research challenge in pure autonomic failure (PAF) lies in identifying specific biomarkers that can differentiate it from the other Lewy body disorders (Parkinson’s disease, Parkinson’s disease dementia, dementia with Lewy bodies) and multiple system atrophy in the early stages and predict phenoconversion trajectories to more widespread impairment. In this study, we described the natural
-
Correction to: Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females. Brain (IF 10.6) Pub Date : 2025-05-21
-
Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke Brain (IF 10.6) Pub Date : 2025-05-20
Philipp J Koch, Benedikt M Frey, Winifried Backhaus, Nora Petersen, Gabriel Girard, Pawel P Wróbel, Hanna Braaß, Marlene Bönstrup, Lisa Kunkel genannt Bode, Bastian Cheng, Götz Thomalla, Christian Gerloff, Hannes Schacht, Peter Schramm, Georg Royl, Fanny Quandt, Robert SchulzNeuroscience has evolved by framing numerous neuropsychiatric conditions as network diseases. Alterations within neurotransmitter (NT) systems are central to the development of these diseases. Recently, normative data on whole-brain NT fingerprints derived from PET tracer data has become accessible; limited data related such information to sequelae after stroke. This work aims to explore (1) the integration
-
Are brain arteriovenous malformations congenital or developmental? Evidence from paediatric age data Brain (IF 10.6) Pub Date : 2025-05-20
Sivaram S Emani, Ari D Kappel, Shivani D Rangwala, Paulina Piwowarczyk, Nikita Singh, Joon Hyeok Choi, Alfred P See, Darren B OrbachThe natural history of pediatric brain arteriovenous malformations (AVMs) remains uncertain, particularly regarding their origin (congenital versus postnatal) and risk of rupture. This study analyzes age-related patterns in AVM presentation from a single quaternary referral center. A retrospective review of 275 pediatric AVM cases from 2009–2022, was conducted using radiological, surgical, and hospital
-
Direct electrical stimulation maps white matter anatomy to function. Brain (IF 10.6) Pub Date : 2025-05-19
Davide Giampiccolo,Guillaume Herbet,Hugues Duffau -
FGF14 repeat length and mosaic interruptions: modifiers of spinocerebellar ataxia 27B? Brain (IF 10.6) Pub Date : 2025-05-17
Joshua Laß, Mirja Thomsen, Max Borsche, Theresa Lüth, Julia C Prietzsche, Susen Schaake, Andona Milovanović, Hannah Macpherson, Emil K Gustavsson, Paula Saffie Awad, Nataša Dragašević-Mišković, Björn-Hergen Laabs, Inke R König, Ana Westenberger, Christopher E Pearson, Norbert Brüggemann, Christine Klein, Joanne TrinhDeep intronic FGF14 repeat expansions have been identified as a frequent genetic cause of late-onset cerebellar ataxias, explaining up to 30% of patients. Interruptions between repeats have previously been identified to impact the penetrance in other repeat expansion disorders. Repeat interruptions within FGF14 have yet to be characterized in detail. We utilized long-range PCR, Sanger sequencing, repeat-primed
-
Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-β pathology and cognitive impairment Brain (IF 10.6) Pub Date : 2025-05-16
Tianqi Yang, Dianjun Zhang, Haiwei Huang, Fangyue Liu, Juanli Wu, Xiaolin Ma, Shuangshuang Liu, Man Huang, Yu-Dong Zhou, Yi ShenAstrocytic dysfunction is a crucial factor for the pathogenesis of Alzheimer’s disease. Metabotropic glutamate receptor 5 (mGluR5) is ubiquitously expressed in the brain and is a key molecule that regulates synaptic transmission and plasticity. It has been shown that mGluR5 is elevated in astrocytes in Alzheimer’s disease. However, it remains elusive how astrocytic mGluR5 contributes to the pathogenesis
-
Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders Brain (IF 10.6) Pub Date : 2025-05-14
Neus Mongay-Ochoa, Gabriel Gonzalez-Escamilla, Vinzenz Fleischer, Deborah Pareto, Àlex Rovira, Jaume Sastre-Garriga, Sergiu GroppaStructural MRI can robustly assess brain tissue alterations related to neurological diseases and ageing. Traditional morphological MRI metrics, such as cortical volume and thickness, only partially relate to functional impairment and disease trajectories at the individual level. Emerging research has increasingly focused on reconstructing interregional meso- and macro-structural relationships in the
-
Neurological complications of orthopoxvirus infections: neurotropism and neurovirulence Brain (IF 10.6) Pub Date : 2025-05-14
Hajar Miranzadeh Mahabadi, Ryan S Noyce, David H Evans, Christopher PowerWith the declaration of monkeypox virus (MPXV) infection as a global health emergency in 2022 by the WHO and its ongoing presence, Orthopoxviruses have garnered increasing attention, including their capacity to cause neurological disease. Indeed, the mpox syndrome caused by MPXV infection is recapitulated in humans for several other Orthopoxviruses including variola (VARV, the cause of smallpox), Vaccinia
-
Medial temporal lobe structural changes when Down syndrome and Alzheimer’s disease collide Brain (IF 10.6) Pub Date : 2025-05-14
Laura E M Wisse, Renaud La JoieThis scientific commentary refers to ‘Medial temporal lobe atrophy in Down syndrome along the Alzheimer’s disease continuum’ by Buehner et al. (https://doi.org/10.1093/brain/awaf133).
-
Filamin A in focus: unravelling the multifaceted roles of filamin A in neurodevelopment and neurological disorders Brain (IF 10.6) Pub Date : 2025-05-14
Longbo ZhangNeurodevelopment is an intricate process encompassing the proliferation, differentiation, migration, and maturation of neural cells. Disruptions in these tightly regulated events can lead to a variety of neurodevelopmental disorders. Filamin A (FLNA), a key actin-binding protein, plays a pivotal role in regulating neuronal migration, morphological development, and synaptic connectivity by modulating
-
Classifying neurogenic dysphagia as a movement disorder Brain (IF 10.6) Pub Date : 2025-05-14
Corinne A Jones, Maggie-Lee Huckabee, Georgia A Malandraki, David PaydarfarSwallowing is a complex sensorimotor task critical for maintaining nutrition, hydration, and quality of life. Given the widespread neural involvement and combined volitional and reflexive control, many neurologic conditions can result in swallowing disorders (dysphagia). There is no classification framework for neurogenic dysphagia according to where dysfunction lies within the sensorimotor hierarchy
-
Souvenirs of an awake craniotomy Brain (IF 10.6) Pub Date : 2025-05-13
Camille BéginWhat do you, a bilingual person, do when a surgeon asks which language you wish to keep as he is about to perform an awake craniotomy to remove your right frontal lobe brain tumour? Winner of the Brain Essay Competition 2024, Camille Bégin shares her personal experience of brain surgery.
-
-
We're all in this together: a rejoinder to Masud Husain's (rant) editorial. Brain (IF 10.6) Pub Date : 2025-05-13
Fritz Sager,Hugues Abriel,Markus Brönnimann,Andrew Chan,Heike Mayer,Virginia Richter -
Bullshit jobs and bullshit job holders: a defence. Brain (IF 10.6) Pub Date : 2025-05-13
Rachel M Msetfi,Diana E Kornbrot -
Against the moral hemiplegia of the intellectual class. Brain (IF 10.6) Pub Date : 2025-05-13
José Alberto González Cáceres -
Overcoming the dopamine-centric model of impulse control disorders in Parkinson’s disease: the role of 5-HT Brain (IF 10.6) Pub Date : 2025-05-13
Roberto Cilia, Valtteri KaasinenThis scientific commentary refers to ‘Serotonergic dysfunction in patients with impulse control disorders in Parkinson’s disease’ by Prange et al. (https://doi.org/10.1093/brain/awaf087).
-
Understanding brain calcification via N-terminal acetylation at the Golgi apparatus Brain (IF 10.6) Pub Date : 2025-05-09
Anette Siggervåg, Åse K Bekkelund, Jaakko Saraste, Henriette AksnesPrimary familial brain calcification (PFBC) provides valuable insights into the mechanisms underlying brain calcification as it singles out the proteins that potentially are involved in the relevant cellular pathways. To date, seven genes have been linked to PFBC, and studying their encoded proteins marks an exciting new era in understanding the disease mechanisms, which may ultimately lead to therapeutic
-
Functional contribution of astrocytic Kir4.1 channels to spasticity after spinal cord injury Brain (IF 10.6) Pub Date : 2025-05-07
Tony Barbay, Emilie Pecchi, Jorge Ramirez-Franco, Anton Ivanov, Frédéric Brocard, Nathalie Rouach, Rémi BosSpasticity, a prevalent motor issue characterized by network hyperexcitability, causes pain and discomfort, with existing treatments offering limited relief. While past research has focused on neuronal factors, the role of astrocytes in spasticity has been overlooked. This study explores the potential of restoring astrocytic potassium (K+) uptake to reduce spasticity following spinal cord injury (SCI)
-
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis Brain (IF 10.6) Pub Date : 2025-05-06
Gavin Giovannoni, Louisa James, Adekunle A Adeniran, Julian Gold, Lawrence S Young, David L Selwood, David Baker, Ruth DobsonEpstein-Barr virus (EBV) is strongly associated with multiple sclerosis (MS). It is likely to play a causal role in the pathogenesis of MS, possibly via triggering autoimmunity through molecular mimicry, autoantigenic presentation or immune dysregulation. Alternatively, evidence supports a direct role for EBV in driving MS disease activity via latent-lytic infection cycling either within the central
-
Diagnosing migraine from genome-wide genotype data: a machine learning analysis. Brain (IF 10.6) Pub Date : 2025-05-06
Antonios Danelakis,Tjaša Kumelj,Bendik S Winsvold,Marte Helene Bjørk,Parashkev Nachev,Manjit Matharu,Dominic Giles,,Erling Tronvik,Helge Langseth,Anker StubberudMigraine has an assumed polygenic basis, but the genetic risk variants identified in genome-wide association studies only explain a proportion of the heritability. We aimed to develop machine learning models, capturing non-additive and interactive effects, to address the missing heritability. This was a cross-sectional population-based study of participants in the second and third Trøndelag Health
-
Mitochondria as the key to understanding neuroinflammation. Brain (IF 10.6) Pub Date : 2025-05-06
Tamas Kozicz,Eva Morava -
Cholinergic degeneration in prodromal and early Parkinson’s: a link to present and future disease states Brain (IF 10.6) Pub Date : 2025-05-06
Tamir Eisenstein, Karolien Groenewald, Ludo van Hillegondsberg, Falah Al Hajraf, Tanja Zerenner, Michael A Lawton, Yoav Ben-Shlomo, Ludovica Griffanti, Michele T Hu, Johannes C KleinThe neuropathological process in Parkinson’s disease (PD) and Lewy body disorders has been shown to extend well beyond the degeneration of the dopaminergic system, affecting other neuromodulatory systems in the brain which play crucial roles in the clinical expression and progression of these disorders. Here, we investigate the role of the macrostructural integrity of the nucleus basalis of Meynert
-
More is more: combining therapies to enhance spinal cord injury recovery Brain (IF 10.6) Pub Date : 2025-05-06
Paulina S Scheuren, Emmanuel Ogalo, Michael J Berger, John L K KramerThis scientific commentary refers to ‘Combinatorial approaches increasing neuronal activity accelerate recovery after spinal cord injury’ by Chen et al. (https://doi.org/10.1093/brain/awaf099).
-
Oxygen extraction fraction in small vessel disease: relationship to disease burden and progression Brain (IF 10.6) Pub Date : 2025-05-05
Ruiting Zhang, Miao Lin, Junghun Cho, Xinfeng Yu, Yeerfan Jiaerken, Shuyue Wang, Hui Hong, Xiaojun Guan, Yao Zhang, Linyun Xie, Lingyun Liu, Lei Cui, Minming Zhang, Geert Jan Biessels, Jeroen C W Siero, Peiyu HuangChronic hypoperfusion has been considered a major mechanism of cerebral small vessel disease. Nonetheless, brain tissue may increase oxygen extraction fraction to mitigate hypoxia and delay parenchymal damage. This study aims to investigate oxygen extraction fraction in cerebral small vessel disease and understand its relationship to disease burden and progression. We retrospectively included 195 patients
-
Common neuropathologic change drivers of hippocampal sclerosis of ageing Brain (IF 10.6) Pub Date : 2025-05-05
Davis C Woodworth, Jerry J Lou, William H Yong, Elizabeth Head, María M Corrada, Peter T Nelson, S Ahmad SajjadiHippocampal sclerosis of aging (HS-A) –severe cell loss and gliosis in the hippocampal formation– is a neuropathologic change (NC) that affects up to 20% of elderly persons with dementia. The etiology of HS-A is heterogeneous, but HS-A is strongly associated with limbic-predominant age-related TDP-43 encephalopathy NC (LATE-NC). Other NCs have also been implicated in relation to HS-A, but these associations
-
Cell-specific Eif2b5 mutant mice: novel insights into roles of macroglia in vanishing white matter Brain (IF 10.6) Pub Date : 2025-05-03
Javier Triñanes-Ramos, Marianna Bugiani, Gemma van Rooijen-van Leeuwen, Juliette A Chevalier, Yuan Jiew Siu, Elise L H van Utenhove, Leoni Hoogterp, Diede Witkamp, Ellen Oudejans, Bastiaan Lodder, Maarten Kole, Gesine Saher, Klaus-Armin Nave, Truus E M Abbink, Marjo S van der KnaapVanishing white matter (VWM) is a leukodystrophy caused by mutations in any of the genes encoding the subunits of the eukaryotic translation initiation factor 2B (eIF2B), a central factor in mRNA translation initiation and regulator of the translation rate during the integrated stress response (ISR). Clinically, VWM is characterized by chronic motor and cognitive decline and premature death. Neuropathology
-
Beyond a syndrome: a mechanism for depression in Parkinson’s disease Brain (IF 10.6) Pub Date : 2025-05-02
Campbell Le Heron, Trevor T -J ChongThis scientific commentary refers to ‘Impaired reward sensitivity in Parkinson’s depression is unresponsive to dopamine treatment’ by Costello et al. (https://doi.org/10.1093/brain/awaf098).
-
Altered T-cell reactivity in the early stages of Alzheimer’s disease Brain (IF 10.6) Pub Date : 2025-04-30
Chiara Rickenbach, Anna Mallone, Lars Häusle, Larissa Frei, Sarina Seiter, Colin Sparano, Tunahan Kirabali, Kaj Blennow, Henrik Zetterberg, Maria Teresa Ferretti, Luka Kulic, Christoph Hock, Roger M Nitsch, Valerie Treyer, Anton Gietl, Christoph GerickeThe adaptive immune system and neurodegenerative Alzheimer’s disease (AD) are intertwined in multiple ways. Recent studies have reported alterations of the adaptive immune system in early AD stages, such as preclinical AD and mild cognitive impairment (MCI) due to AD. However, the identity of specific antigenic targets and whether the respective response is beneficial or detrimental during disease
-
Pleiotropic effects of MORC2 derive from its epigenetic signature Brain (IF 10.6) Pub Date : 2025-04-30
Fatemeh Peymani, Tomohiro Ebihara, Dmitrii Smirnov, Robert Kopajtich, Masahiro Ando, Enrico Bertini, Rosalba Carrozzo, Daria Diodato, Felix Distelmaier, Fang Fang, Daniele Ghezzi, Maja Hempel, Katarzyna Iwanicka-Pronicka, Thomas Klopstock, Sarah L Stenton, Costanza Lamperti, Zhimei Liu, Aysylu Murtazina, Yuji Okamoto, Yasushi Okazaki, Dorota Piekutowska-Abramczuk, Agnés Rötig, Oxana Ryzhkova, ChristianHeterozygous missense mutations in MORC2 have been implicated in various clinical entities, ranging from early-onset neurodevelopmental disorders to late-onset neuropathies. The mechanism underlying the phenotypic heterogeneity and pleiotropic effects of MORC2 has remained elusive. Here, we analyzed blood and fibroblast DNA methylation, transcriptomes, proteomes, and phenotypes of 53 MORC2 patients
-
Correction to: Nigrostriatal tau pathology in parkinsonism and Parkinson's disease. Brain (IF 10.6) Pub Date : 2025-05-13
-
At-home wearables and machine learning capture motor impairment and progression in adult ataxias Brain (IF 10.6) Pub Date : 2025-04-29
Rohin Manohar, Faye X Yang, Christopher D Stephen, Jeremy D Schmahmann, Nicole M Eklund, Anoopum S GuptaA significant barrier to developing disease-modifying therapies for spinocerebellar ataxias (SCAs) and multiple system atrophy of the cerebellar type (MSA-C) is the scarcity of tools to sensitively measure disease progression in clinical trials. Wearable sensors worn continuously during natural behavior at home have the potential to produce ecologically valid and precise measures of motor function
-
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapy Brain (IF 10.6) Pub Date : 2025-04-29
Thomas O Millner, Pratistha Panday, Yunchen Xiao, James Nicholson, James R Boot, Zsharmaine Arpe, Paul A Stevens, Nadia N Rahman, Xinyu Zhang, Charles Mein, Neil Kitchen, Andrew W McEvoy, Edward McKintosh, Grainne S McKenna, Dimitrios Paraskevopoulos, Nicolae Radu Zabet, Rachel Lewis, Sara Badodi, Silvia MarinoTargeted radiotherapy (RT) is integral to the increasing survival of cancer patients; however, it has significant side-effects, the underlying cellular and molecular mechanisms of which are ill-defined. It is well documented that RT induces epigenetic changes in neoplastic tissue, which impacts tumour evolution, however whether epigenetic deregulation also occurs in the surrounding non-neoplastic tissue
-
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease Brain (IF 10.6) Pub Date : 2025-04-28
Jessica Guerra, Mirella Belleri, Elisa Scalvini, Davide Capoferri, Chiara Tobia, Cosetta Ravelli, Marzia Corli, Nicole Bresciani, Josefina Casas, Gemma Fabrias, Michele Dei Cas, Marco Presta, Luca MignaniKrabbe disease (KD) is an autosomal recessive sphingolipidosis due to mutations of the GALC gene encoding for the lysosomal β-galactosylceramidase (GALC) that removes β-galactose from β-galactosylceramide, β-lactosylceramide (LacCer), and the neurotoxic metabolite β-galactosylsphingosine (psychosine). At present, the accumulation of psychosine is thought to be the main cause of demyelination, neurodegeneration
-
Emerging roles of transfer RNA fragments in the CNS Brain (IF 10.6) Pub Date : 2025-04-28
Katarzyna Winek, Hermona SoreqtRNA-derived small RNAs (tsRNAs), previously considered inactive tRNA degradation products, have now been shown to be functional small noncoding RNAs. They may play important roles within the central nervous system (CNS) and in brain-body interactions both during normal developmental stages as well as in diverse brain pathologies. Among the cell types found in the CNS, tsRNAs are most abundant in neurons
-
Making a diagnosis of Alzheimer's disease in asymptomatic individuals with positive biomarkers Brain (IF 10.6) Pub Date : 2025-04-28
Nunzio Pomara, Bruno Pietro ImbimboAbout 25% of cognitively unimpaired older adults have an elevated brain amyloid burden comparable to that of individuals with symptomatic Alzheimer’s disease. Pomara and Imbimbo examine the ongoing debate over whether these individuals should be classified as having preclinical Alzheimer’s disease or simply be considered ‘at risk’.
-
Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophy Brain (IF 10.6) Pub Date : 2025-04-26
Alberto A Zambon, Paola M V Rancoita, Angelo Quattrini, Calogera Butera, Francesco Gentile, Marcella Facchini, Sara Mazza, Salvatore Recupero, Vera Gallo, Andrew Shenker, Nicholas D Gollop, Ubaldo Del Carro, Valeria Calbi, Clelia Di Serio, Maria Grazia Natali Sora, Massimo Filippi, Alessandro Aiuti, Francesca FumagalliThis study evaluates the efficacy of arsa-cel gene therapy (GT) in mitigating the severity and progression of peripheral neuropathy as assessed by nerve conduction velocity (NCV) in individuals affected by late-infantile metachromatic leukodystrophy (LI-MLD). This is a post-hoc analysis conducted on pre-symptomatic patients affected by LI-MLD treated with ex vivo autologous hematopoietic stem cell
-
Interferon-γ causes myogenic cell dysfunction and senescence in immune myopathies Brain (IF 10.6) Pub Date : 2025-04-25
Cyrielle Hou, Baptiste Periou, Marianne Gervais, Ludovic Martin, Juliette Berthier, Yasmine Baba-Amer, Sarah Souvannanorath, Emmanuele Lechapt-Zalcman, Edoardo Malfatti, Romain K Gherardi, Fréderic Relaix, Maximilien Bencze, François Jérôme AuthierIdiopathic immune myopathies (IIM) represent a heterogeneous group of diseases, in which muscle lesions result from deregulated immune reactions. Typical histological features include myofibre necrosis, leukocyte infiltration, and aberrant myofibre Major Histocompatibility Complex (MHC) expression. To investigate the link between MHC expression, inflammation, and muscle lesions, muscle biopsies from
-
A mouse model of GRIN2D developmental and epileptic encephalopathy recapitulates the human disease Brain (IF 10.6) Pub Date : 2025-04-25
Mor Yam, Jolan Nassir, Danielle Galber, Shir Quinn, Roni Gal, Mor Ovadia, Mor Bordeynik-Cohen, Eden Peled, Christopher D Makinson, Moran Hausman Kedem, Aviva Fattal-Valevski, Wayne N Frankel, Karen B Avraham, Moran RubinsteinPathogenic variants in GRIN2D, encoding one of the subunits of the NMDA receptor (NMDAR), are associated with developmental and epileptic encephalopathies (DEEs). Unusual for de novo mutations, the recurrent, de-novo, gain of function, missense mutation c.1999G>A (p.Val667Ile) was discovered in multiple patients. We characterized a mouse model carrying the orthologous Grin2d mutation, using behavioral
-
Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination Brain (IF 10.6) Pub Date : 2025-04-25
Ahmed Abdelhak, Christian Cordano, Greg J Duncan, Katie Emberley, Sonia Nocera, Wendy Xin, Kirtana Ananth, Nour Jabassini, Kiarra Ning, Henriette Reinsberg, Frederike Cosima Oertel, Alexandra Beaudry-Richard, Jens Kuhle, Axel Petzold, Praveen J Patel, Ana P Ribeiro Reis, Paul Foster, Trent Watkins, Jonah Chan, Ben Emery, Ari J GreenNeuroaxonal injury is a major driver of irreversible disability in demyelinating conditions. Accurate assessment of the association between demyelination and axonal pathology is critical for evaluating and developing effective therapeutic approaches. Measuring neurofilament light chain (NfL) in blood could putatively allow longitudinal monitoring of neuroaxonal injury at “single protein resolution”
-
Correction of sodium channel mutations in sensory neurons reverses aberrant properties Brain (IF 10.6) Pub Date : 2025-04-25
Jaehoon Shim, Brian Tanaka, Daniel G Taub, Malgorzata A Mis, Betsy R Schulman, Andrew Snavely, Yung-Chih Cheng, Cedric Laedermann, Elizabeth D Buttermore, Alexander Ren, Crystal Hermawan, Dan Dou, Riki Kawaguchi, Daniel H Geschwind, Sulayman Dib-Hajj, Stephen G Waxman, Clifford J WoolfInherited erythromelalgia, small fiber neuropathy and paroxysmal extreme pain disorder are caused by gain-of-function mutations in the voltage gated sodium channel Nav1.7. How different mutations in the same channel enhancing electrogenesis in sensory neurons results in such distinct disease presentations remains unknown. Most of the work analysing the impact of these mutations on electrophysiological
-
Neuropsychiatric symptoms and progression to pathologically confirmed Alzheimer’s disease Brain (IF 10.6) Pub Date : 2025-04-25
Sergio F Sharif, Dylan X Guan, Tamara Bodnar, Jeffery T Joseph, Henrik Zetterberg, Eric E Smith, Zahinoor IsmailWhether or not neuropsychiatric symptoms (NPS) in advance of dementia are associated with Alzheimer disease (AD) and/or other neurodegenerative dementias remains to be determined. The mild behavioural impairment (MBI) construct selects persons with NPS that are later-life emergent and persistent to identify a high-risk group for cognitive decline and incident dementia. Here, in older adults without
-
Shedding light on a novel circuit within primary motor cortex as a target for neuromodulation. Brain (IF 10.6) Pub Date : 2025-05-13
Caroline Tscherpel,Christian Grefkes